BNY Mellon International Stock Index Fund
DIISX
NASDAQ- -
USD
- -
- -
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Sector
- Financial Services
- Industry
- Asset Management
- Address
- NEW YORK NY 10166 New York NY United States of America 10166
- IPO Date
- Jun 30, 1997
- CIK
- 0000857114
- Website
- bny.com
- Similar Companies
- Business
- BNY Mellon International Stock Index Fund (DIISX) is an open-end mutual fund that seeks to match the performance of the Morgan Stanley Capital International Europe, Australasia, Far East Free Index (MSCI EAFE Index), a free float-adjusted market capitalization-weighted benchmark measuring developed market equity performance outside the U.S. and Canada; the fund normally invests substantially all of its assets in a representative sample of stocks included in the index or in futures contracts tied to the index, aiming for a correlation of at least 0.95 with the benchmark before expenses. It offers Investor Shares (ticker: DIISX, CUSIP: 09661L500) with a net expense ratio of 0.60%, including a 0.35% management fee, 0.25% service fee, and minimal other expenses, alongside multiple share classes for institutional and other investors; the fund maintains low portfolio turnover of approximately 3-4% and distributes annual qualified dividends, with a 2024 payout of $0.6020 per share. Managed by a team at Mellon Investments Corporation including David France, CFA (since 2020), Todd Frysinger, CFA (since 2020), Vlasta Sheremeta, CFA (since 2020), Michael Stoll (since 2020), and Marlene Walker Smith (since 2020), the fund targets individual and intermediary investors seeking foreign large blend exposure, with total net assets of approximately $335-341 million USD as of late 2025 and holdings concentrated in non-U.S. stocks (around 96%), cash equivalents, and minimal U.S. equities. Launched on June 30, 1997, and domiciled in the United States, the fund operates under BNY Mellon Investment Adviser, Inc., part of BNY Investments headquartered at 240 Greenwich Street, New York, NY. In recent years, the fund has maintained stable management with no major portfolio or structural changes reported; it continues to track the MSCI EAFE Index closely amid strong 2025 year-to-date returns exceeding 28%, reflecting robust performance in benchmark-aligned holdings such as Novo Nordisk, ASML Holding, SAP SE, and AstraZeneca, while adhering to its passive indexing strategy without defensive adjustments or active shifts.